Cognoa Signs an Exclusive License Agreement with Stanford for its Google Glass-based Technology for Children with Autism Spectrum Disorder (ASD)

 Cognoa Signs an Exclusive License Agreement with Stanford for its Google Glass-based Technology for Children with Autism Spectrum Disorder (ASD)

Cognoa Signs an Exclusive License Agreement with Stanford for its Google Glass-based Technology for Children with Autism Spectrum Disorder (ASD)

Shots:

  • Cognoa to get exclusive license rights for Stanford’s Google Glass-based autism technology to develop & commercialize digital therapies for children with autism spectrum disorder (ASD)
  • The Superpower Glass (SG) intervention deployed via Google Glass and a mobile app is evaluated in 71 children with ASD and resulted in improvement in socialization, play and coping skills than those with SOC for ASD
  • The SG is a wearable intervention which tracks the face, classify emotions, providing two form of cues, first with a green indicator and in second an emoticon appears to the child in real time. Cognoa has also received the US FDA’s BT designation for its first therapeutic device using the technology

Click here to read full press release/ article | Ref: GlobeNewsWire | Image: WSJ

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post